Cargando…
Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization, Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells
Doxorubicin (DOX) is a chemotherapeutic agent is used for various cancer cells. To characterize the chemical structural components and metabolic inhibition, we applied a DOX to HCT116 colon cancer cells using an independent metabolites profiling approach. Chemical metabolomics has been involved in t...
Autores principales: | Ganesan, Raja, Prabhakaran, Vasantha-Srinivasan, Valsala Gopalakrishnan, Abilash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694538/ https://www.ncbi.nlm.nih.gov/pubmed/36355130 http://dx.doi.org/10.3390/metabo12111047 |
Ejemplares similares
-
Solid-State NMR-Based Metabolomics Imprinting Elucidation in Tissue Metabolites, Metabolites Inhibition, and Metabolic Hub in Zebrafish by Chitosan
por: Ganesan, Raja, et al.
Publicado: (2022) -
A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
por: Kannampuzha, Sandra, et al.
Publicado: (2023) -
Role of Metabolism and Metabolic Pathways in Prostate Cancer
por: Wanjari, Uddesh Ramesh, et al.
Publicado: (2023) -
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells
por: Sabit, Hussein, et al.
Publicado: (2016) -
Entrainment of superoxide rhythm by menadione in HCT116 colon cancer cells
por: Kizhuveetil, Uma, et al.
Publicado: (2019)